Surgical Complications of Endoscopic Approach to Skull Base: Analysis of 584 Consecutive Patients Publisher Pubmed



Taghvaei M^{1, 2} ; Fallah S^{1, 2} ; Sadaghiani S² ; Sadrhosseini SM³ ; Tabari A³ ; Fathi M^{1, 2} ; Zeinalizadeh M^{1, 2} Show Affiliations
Source: European Archives of Oto-Rhino-Laryngology Published:2022

Abstract

Purpose: Endoscopic techniques have been widely applied for challenging cranial base surgeries in recent years. In this study, we evaluated the safety and efficacy of using the endoscopic endo-nasal route for various skull base pathologies in terms of postoperative complications. Methods: A total of 584 consecutive patients who underwent endoscopic skull base surgery were studied. Peri- and post-operative complications and risk factors affecting the occurrence of these complications were evaluated. Results: 648 endoscopic skull base surgical procedures were performed on 584 patients (47.8% females and 52.2% males) with the mean age of 41.2 years. Pituitary adenoma (69.3%) was the most common pathology. Post-operative mortality was 2.0%. The rates of post-operative permanent neurological deficit (one case of 6th nerve injury, two 12th nerve injuries and one hemiparesis) and visual deterioration were 0.6% and 1.5%, respectively. Ten patients (1.7%) were complicated with meningitis and it was the cause of death in 3. Systemic complications not directly attributable to skull base surgical access occurred in 2% (11 patients) with 5 mortalities. The rate of intra-operative vascular injury was 1% and among them one patient died due to PCA injury. The most common post-operative complications were diabetes insipidus (12.5%), anterior pituitary dysfunction (10.6%) and CSF leak (3.6%), respectively. In general, reoperation, malignant lesions, and level IV of surgical complexity were associated with a higher incidence of complications. Conclusion: Endoscopic endo-nasal approach can be a safe and less-morbid first-line treatment of patients with various skull base lesions. © 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.